Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
The CEO behind IgniteTech, Khoros and GFI Software will discuss how AI-driven companies accelerate product innovation and human capability ...
The firm noted that Kimberly-Clark is paying a “significant equity premium” to acquire Kenvue. The deal values Kenvue at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback